The Impact of Hydrocephalus Shunt Devices on Quality of Life
- PMID: 34319679
- DOI: 10.1097/SCS.0000000000007579
The Impact of Hydrocephalus Shunt Devices on Quality of Life
Abstract
Background: Despite advances in hydrocephalus shunt technology and improvement in hydrocephalus management, many patients have chronic disability and require multiple surgeries throughout their lifetime. There is limited data from patients' perspective regarding the impact of shunt devices on quality-of-life.
Methods: A cross-sectional survey was developed to evaluate the impact of shunt devices on patient quality-of-life. The survey was distributed via social media platforms of the Hydrocephalus Association, and patients self-selected to anonymously complete the online questionnaire. A literature review was performed to contextualize the findings from the survey.
Results: A total of 562 survey responses were obtained from a network encompassing 35,000 members. The mean age was 30 years old (0.5-87), and 65% identified as female. Eighty one percent underwent at least 1 shunt revision surgery, with a reported average of 10 shunt revision surgeries per patient (1-200 surgeries). Occlusion, shunt migration and infection were the leading causes for revision at 60%, 47%, and 35%, respectively. In addition, 72% of patients reported pain and discomfort from the device, and 68% expressed avoidance of certain activities due to "fear of bumping shunt." Despite numerous articles discussing shunt technology, a review of the literature indicated a paucity of studies specifically evaluating the burden of shunt devices from a patient/caregiver perspective.
Conclusions: The findings from this study suggest long-term physical and psychosocial burden associated with shunt devices. Importantly, this study highlights the need for concerted efforts to develop validated tools to study patient reported outcomes as it relates to neurocranial implanted devices.
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Mutaz B. Habal, MD.
Conflict of interest statement
Dr Gordon is a consultant for Stryker, OsteoMed, DePuy-Synthes, and Longeviti Neuro Solutions. Dr Huang and Dr Gordon are stockholders in Longeviti Neuro Solutions. All other authors report no conflicts of interest.
References
-
- Isaacs AM, Riva-Cambrin J, Yavin D, et al. Age-specific global epidemiology of hydrocephalus: systematic review, metanalysis and global birth surveillance. PLoS One 2018; 13:e0204926.
-
- Isaacs AM, Bezchlibnyk YB, Yong H, et al. Endoscopic third ventriculostomy for treatment of adult hydrocephalus: long-term follow-up of 163 patients. Neurosurg Focus 2016; 41:E3.
-
- Reddy GK, Bollam P, Caldito G. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. World Neurosurg 2014; 81:404–410.
-
- Stein SC, Guo W. Have we made progress in preventing shunt failure? A critical analysis. J Neurosurg Pediatr 2008; 1:40–47.
-
- Gordon CR, Wolff A, Santiago GF, et al. First-in-human experience with integration of a hydrocephalus shunt device within a customized cranial implant. Oper Neurosurg (Hagerstown) 2019; 17:608–615.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical